Trump Is Guilty of Pandemicide History will show the

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks
281
Trump Is Guilty of Pandemicide

History will show the former U.S. president was staggeringly negligent during the pandemic’s deadly third wave.


BY LAURIE GARRETT | FEBRUARY 18, 2021, 5:00 PM

At long last, we see glimmers of hope. The COVID-19 epidemic in the United States has fallen below the numbers of daily new cases tallied on the eve of the presidential election, the point at which this viral nightmare soared. Using the New York Times’ coronavirus data tracker, on Nov. 1, 2020, there were 74,195 new cases counted in the country; by Feb. 16, new case reports came in at 64,376.

But in between those dates, a national horror unfolded, peaking on Jan. 8 with 300,619 new cases reported in just 24 hours. This staggering wave, one full year into the pandemic, was completely unnecessary for the world’s richest country. Achieving any sense of closure will require holding Donald Trump accountable for the failure.

There is vast evidence of Trump’s negligence during the pandemic’s third wave. Had I been a member of the House of Representatives during the body’s impeachment deliberations, I would have added to Trump’s indictment the crime of pandemicide, naming him as responsible for most of the COVID-19 deaths that transpired while he, the nation’s leader, was preoccupied with damning Joe Biden’s election victory.

Trump’s failure to, as he vowed in his oath of office, “faithfully execute the office of president of the United States” promulgated a scale of lives lost exceeding anything experienced in the country since the Civil War, 160 years ago.

I do not accuse Trump of pandemicide in reference to mistakes made by his administration between January 2020—when it generally ignored the outbreak in Wuhan, China—and the summer surge of cases and deaths across the United States.

I do not charge pandemicide over Trump’s Feb. 26, 2020, dismissal of the COVID-19 threat as miniscule, claiming, “The level that we’ve had in our country is very low, and those people are getting better, or we think that in almost all cases they’re better or getting. We have a total of 15.”

Nor do I charge pandemicide over his repeated insistence that COVID-19 cures were available in the forms of hydroxychloroquine, bleach, ultraviolet light, convalescent plasma therapy, the Regeneron cocktail, oleander extract, or simply warm weather.

And though there is striking evidence that the policies of the four-year Trump administration vastly worsened life expectancy and mortality rates in the United States, contributing to 461,000 excess deaths in 2018 alone, these are matters of callous, ill-considered policies and brutal budget cuts, preceding the virus’s arrival to U.S. shores.

Pandemicide is not the outcome of ill-advised, ignorant, or outright stupid budget actions and health messages. I do not even level the charge over Trump’s denunciation of mask use and opposition to temporary business and school closures to halt the spread of SARS-CoV-2, encouraging people to “liberate” states that were implementing tough lockdown regulations.

Rather, the path of pandemicide was paved in pursuit of the president’s reelection and his relentless, all-consuming post-election campaign to refute his opponent’s victory, claiming election fraud and even theft.

Despite the summer surge in COVID-19 infections nationwide, Trump abandoned virtual campaigning in favor of crowded, largely maskless gatherings of his supporters, knowingly risking that each rally would become a superspreader event. According to a study by Stanford University, 18 campaign rallies held between June 20 and Sept. 22, 2020, spawned in excess of 30,000 COVID-19 cases, likely leading to more than 700 deaths.

During the same time period, half of Trump’s campaign rallies were followed by COVID-19 surges in the counties in which they took place.

While Biden’s campaign rallies were largely virtual or held in parking areas with participants in their vehicles, Trump’s tightly packed, mostly mask-free throngs increased in both number and frequency, further spreading the virus and causing the U.S. government’s top COVID-19 response expert, Anthony Fauci, to warn that the president was “asking for trouble.”

Even after Trump and the first lady contracted COVID-19, compelling emergency treatment that included, in Trump’s case, hospitalization at Walter Reed National Military Medical Center and round-the-clock treatment from an army of physicians and nurses, the president refused to regularly don a mask.

On the day of his hospital admission, Oct. 2, the United States had cumulatively logged more than 200,000 deaths to COVID-19—an undercount, as are all U.S. COVID-19 numbers, but an official data point that would more than double by the Jan. 20 inauguration of Biden.

According to a new Lancet Commission report compiled by an international team of august scientists and public health leaders, some 40 percent of America’s COVID-19 death toll during the Trump administration was needless, meaning it could have been averted with available nonmedical interventions.

By the time the election took place, Trump had ignored the pandemic, not attending a single COVID-19 White House meeting for at least five months, since late May. Behind the scenes in the fall, the Trump administration lobbied Congress vigorously to block the movement of funds to states for vaccine rollout efforts, leaving them unable to efficiently execute mass immunizations.
.
And going forward from election night, on Nov. 3, to the inauguration on Jan. 20, Trump was fully fixated on overturning Biden’s victory. He ceased speaking to the press on Dec. 8, held no public events after Nov. 4, and made his final public appearance at a Dec. 12 football game.

According to White House schedules, Trump had few official meetings for days, left Washington for Mar-a-Lago on Dec. 23, and did not resurface until New Year’s Eve, when he delivered a video address to the nation celebrating Food and Drug Administration emergency approval of SARS-CoV-2 vaccines.

On Jan. 6, the president delivered his now infamous speech to supporters, exhorting them to march down Pennsylvania Avenue to the Capitol. From Jan. 7 until he moved out of the White House on the morning of Jan. 20, Trump made few public remarks, frustrated by his loss of access to social media.

As his much-touted Operation Warp Speed sputtered, unable to speed vaccines into the arms of Americans, Trump was silent. And the White House became COVID-19 central, with chief of staff Mark Meadows, four other White House staff, Secretary of Housing and Urban Affairs Ben Carson, and David Bossie, Trump’s designated leader of efforts to challenge the election, all infected.

In line with the president’s mantra that COVID-19 wasn’t all that serious—“Don’t let it take over your lives”— none of these individuals regularly wore protective face masks in the White House or on the election-counting trail.

So, I level the charge of pandemicide against Trump for his failure to say or do anything to halt the soaring burden of infection and death across the United States from Election Day to his departure from office.

During a period when experts inside his government warned that holiday travel and interactions over Thanksgiving, Christmas, and New Year’s could lead to massive spread of the virus, and states clamored for aid to disseminate vaccines, Trump was mum.

He ignored the pandemic on Nov. 3, when 92,000 people were newly infected, bringing the nation’s cumulative total to 9.4 million and its death toll to 225,000.

He remained taciturn as more than 1 million Americans per day, over the four-day Thanksgiving weekend, flew on commercial planes and millions more traveled by other means to visit families, despite stay-at-home pleas from the Centers for Disease Control and Prevention. By Nov. 30, more than 13.5 million Americans had tested positive for COVID-19, and 259,000 had died.

As Christmas approached, public health leaders again pleaded for Americans to resist temptation, stay home, and avoid family gatherings. By Dec. 22, 18 million Americans had acquired COVID-19, and 314,000 had died from it. But the president was silent, and, again, millions of Americans traveled and celebrated with friends and families.

As the new year neared, on Dec. 31, the total case count was almost 20 million, with 336,000 deaths. And still, Trump was silent.

As his insurrection mob gathered on Capitol Hill, the case tally topped 21 million, with 352,000 deaths.

And by the time Trump boarded Marine One for his final helicopter ride at taxpayer expense, en route to Mar-a-Lago, 24 million Americans had tested positive with SARS-CoV-2, killing nearly 400,000 of them.

Between the election and the inauguration, the number of infected Americans more than doubled, skyrocketing from 9.4 million cases to 24 million—adding some 15 million cases, on Trump’s watch, when he was fixated on overturning Biden’s victory and AWOL on the pandemic front.

And in his absence from pandemic duty—his duty to protect the American people—172,000 Americans died, nearly doubling the mortality toll since Election Day.

Republicans have, of course, decided that Trump cannot be impeached now that he is a private citizen. As a matter of formality, then, my call is moot.

But let history record that no sitting U.S. president—since April 30, 1789, when George Washington took the first oath on the balcony of Federal Hall on Wall Street in New York City—has willfully allowed such preventable carnage to unfold on the American people.

Let history record that Donald Trump is guilty of the crime of pandemicide.

https://foreignpolicy.com/2021/02/18/trump-is...ndemicide/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aurra Markets Wins 'Most Transparent Broker' Award 2026

Updated Category News Views 1

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

Continue Reading
Spencer Spirit Completes Hot Topic Acquisition

Updated Category News Views 1

Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 2

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading
ITP Media's Bold Move: Ready for Asian Market Surge

Updated Category News Views 1

Pushing Boundaries: ITP Media Group Eyes Asia ITP Media Group isn't here to tiptoe around the media market; they're diving headfirst with the recent takeover of Heart Media Group. A bold move, some might say, in this volatile world of media mergers and acquisitions. But let's break down what this really means. A Strategic Bet on Luxury To start, ITP Media is beefing up...

Continue Reading
XTransfer Revs Up Expansion in the UAE Market

Updated Category News Views 1

In the nitty-gritty world of B2B payments, securing a spot in a powerhouse like the UAE is no small potatoes. XTransfer just snagged an in-principle nod from the UAE Central Bank for a Retail Payment Services Licence, and that's got to feel like sweet validation for a company that's aggressively pushing its regulatory map beyond corners it's already conquered. Eyeing the...

Continue Reading
Immunic Pushes Boundaries in MS with Vidofludimus

Updated Category News Views 2

Shaking Things Up in Multiple Sclerosis Therapy There's no telling how often the biotech sector tosses around the term 'game-changer,' but when Immunic's name comes up, more ears are perking up these days. The New York-based firm, waving the Nasdaq: IMUX flag, is lining up a virtual shindig come September 9, 2026, and for anyone invested in multiple sclerosis (MS) or...

Continue Reading
GoPro's $1.14 Buyout Scrutinized: Fair Value Debate

Updated Category News Views 2

Unpacking the GoPro Buyout Announcement There's some commotion brewing in the investor world, especially if you're clutching onto shares of GoPro (NASDAQ:GPRO). A $1.14 per share buyout has hit the spotlight, and folks are asking if this deal is kosher, particularly when there's $285 million on the line. Does the price truly reflect what GoPro's worth? Ademi LLP is...

Continue Reading
Epson and STOPware Reinvent Visitor Badges for Security

Updated Category News Views 12

Gone are the days when a flimsy monochrome badge was all that stood between a visitor and unrestricted access. Today, Epson and STOPware rock the boat with their new collaboration, offering a game-changing approach to security with full-color badge printing. This isn't just a vanity upgrade; it's about real security enhancement creating immediate visual cues. Shifting the...

Continue Reading
GenesisFX Rolls Out Live Leaderboards, Boosts Social Trading

Updated Category News Views 5

Traders buckle up! GenesisFX Markets just kicked open a new chapter in forex and CFD trading with their Live Leaderboards and beefed-up social trading tools. What's the commotion about? Well, that's your hook. These leaderboards are the newest addition to their ecosystem, paired with some serious social trading muscle. As Arkadiusz Bujalski, the Head of Ops and System...

Continue Reading
stackArmor Secures FedRAMP High: A Strategic Milestone

Updated Category News Views 2

stackArmor: Carving a Niche in Federal Cybersecurity Hey, not every day you wake up to find a company carving its niche in federal cybersecurity quite the way stackArmor is doing. They've recently got their hands on that elusive FedRAMP High authorization for The Armory. What's this mean in English? Well, for starters, these guys are showing they're serious about...

Continue Reading

Top 5 Most Recently Viewed Articles

Roche's Evrysdi Tablet Revolutionizes SMA Treatment Options

Updated Category News Views 195

Roche's Evrysdi Tablet Revolutionizes SMA Treatment Options Roche has recently made a remarkable advancement in the field of spinal muscular atrophy (SMA) treatment with the approval of the Evrysdi® tablet by the European Commission. This new formulation is not just another medication; it symbolizes a significant leap towards enhancing the quality of life for individuals...

Continue Reading
IVX Health Celebrates Recognition as Top Workplace in Healthcare

Updated Category News Views 138

IVX Health Honored by Modern Healthcare IVX Health has been recognized by Modern Healthcare as one of the Best Places to Work in Healthcare for 2024. This esteemed honor reflects the company's commitment to excellence within the healthcare sector. The annual program highlights 150 distinguished organizations that excel in fostering a supportive and engaging workplace, and...

Continue Reading
NAMI Strengthens Leadership to Address Mental Health Challenges

Updated Category News Views 174

New Board Leadership at the National Alliance on Mental Illness The National Alliance on Mental Illness (NAMI) has announced significant changes in its leadership to tackle the growing mental health crisis in the United States. This newly elected board for the 2025-2026 term comprises dedicated individuals with personal and community ties to mental health advocacy,...

Continue Reading
In-Depth Insights into Depression Treatment Market Trends

Updated Category News Views 208

Overview of the Depression Treatment Market The depression treatment market is seeing a notable surge fueled by increasing mental health awareness and a rising number of individuals affected by this serious condition. With over 280 million people globally struggling with depression, the ongoing advancements in treatment options, including innovative antidepressants and...

Continue Reading